English Summary - Use of the prostate-specific antigen (PSA) test in prostate cancer screening in Québec (portrait)

Because SgII expression is up-regulated both in vivo in high grade PCa and in vitro in androgen-deprived LNCaP cells, we next questioned whether SgII might be an essential effector

L’os étant le site métastatique le plus fréquent chez les patients atteints d’un cancer de la prostate, de nombreux essais cliniques ont évalué l’utilisation de

Risks and drawbacks associated with PSA-based prostate cancer screening The risk of a false-positive result is high, and the low positive predictive value indicates that a

Data from the European Randomised Study of Screening for Prostate Cancer (ERSPC) are used here to show the balance between the potential risks and benefits associated with the

The objectives of this study are to quantify changes in PSA testing in Ontario males aged 35 or older from 2003 to 2012, and to study the associa- tion of selected factors,

Of the 57 men considered in the study, 54 (95%) believed that using the PSA blood test as a screening tool for prostate cancer was not risky, 39 (68%) believed that the PSA blood

Given that my father had incidental prostate cancer later in his life, and considering myself to be at some increased risk, I enrolled in the multicentre

Somewhat less than one in ten women in this age group in the EU (8%) is targeted by regional cervical cancer screening programmes in five Member States, with a